<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00848250</url>
  </required_header>
  <id_info>
    <org_study_id>071078</org_study_id>
    <nct_id>NCT00848250</nct_id>
  </id_info>
  <brief_title>Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children</brief_title>
  <official_title>Effects of Angiotensin Converting Enzyme Inhibition During and After Cardiopulmonary Bypass in Infants and Children With Congenital Heart Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether ACE inhibitors alter the fibrinolytic,
      inflammatory, and hemodynamic response to cardiopulmonary bypass in infants and children with
      congenital heart disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>(PAI-1) Plasminogen Activator Inhibitor -1 Antigen</measure>
    <time_frame>Baseline (prior to surgery), On CPB for 30 minutes, At completion of CPB, and postoperative day 1 (at 8:00AM)postoperative day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>t-PA (Tissue-type Plasminogen Activator) Antigen</measure>
    <time_frame>Baseline (prior to surgery) to postoperative day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>IL-6 (Interleukin-6)</measure>
    <time_frame>Baseline (pre-surgery) to postoperative day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-8 (Interleukin-8)</measure>
    <time_frame>Baseline (pre-surgery) to postoperative day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(MAP) Mean Arterial Blood Pressure</measure>
    <time_frame>Baseline (prior to surgery) to postoperative day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Bleeding</measure>
    <time_frame>24 hours</time_frame>
    <description>Chest tube output at 4 and 24 hours after completion of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Renal Function</measure>
    <time_frame>Baseline (prior to surgery) to postoperative day 1</time_frame>
    <description>Acute kidney injury occurring</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>ACE inhibitor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients already on an ACE inhibitor will continue it until the day of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No ACE inhibitor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Angiotensin Converting Enzyme Inhibitor</intervention_name>
    <description>Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
    <arm_group_label>ACE inhibitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No ACE Inhibitor</intervention_name>
    <description>Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
    <arm_group_label>No ACE inhibitor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants or children (newborn to 17 years of age) undergoing cardiopulmonary bypass for
             elective surgical correction of a congenital heart defect.

          -  Patients must be taking an ACE inhibitor prior to their operation

        Exclusion Criteria:

          -  Patients in which discontinuing ACEIs is deemed unsafe by their primary cardiologist

          -  Any condition rendering the subjects legal guardian unable to understand the nature,
             scope, and possible consequences of the study.

          -  Pregnancy as ruled out by standard of care screening procedures.

          -  Individuals whose weight is less than 3.5 kg at the time of enrollment.

          -  Inability to comply with the protocol. ie. Children in whom it is deemed unsafe to
             have the extra blood draws, and children who are thought to be noncompliant with their
             medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory A Fleming, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center, Division of Pediatric Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mias Pretorius, MBChB, MSCI</last_name>
    <role>Study Director</role>
    <affiliation>Vanderbilt University Medical Center, Department of Anesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Monroe Carell Jr. Children's Hospital at Vanderbilt</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2009</study_first_submitted>
  <study_first_submitted_qc>February 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2009</study_first_posted>
  <results_first_submitted>May 1, 2017</results_first_submitted>
  <results_first_submitted_qc>June 26, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 26, 2017</results_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Gregory Fleming</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Cardiopulmonary Bypass</keyword>
  <keyword>ACE inhibitor</keyword>
  <keyword>Pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enzyme Inhibitors</mesh_term>
    <mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>29 participants were eligible, 8 refused participation</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ACE Inhibitor</title>
          <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
        </group>
        <group group_id="P2">
          <title>No ACE Inhibitor</title>
          <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>surgery was completed without cardiopulm</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ACE Inhibitor</title>
          <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
        </group>
        <group group_id="B2">
          <title>No ACE Inhibitor</title>
          <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.7" spread="3.5"/>
                    <measurement group_id="B2" value="20.8" spread="6.5"/>
                    <measurement group_id="B3" value="17.2" spread="5.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>(PAI-1) Plasminogen Activator Inhibitor -1 Antigen</title>
        <time_frame>Baseline (prior to surgery), On CPB for 30 minutes, At completion of CPB, and postoperative day 1 (at 8:00AM)postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
          <group group_id="O2">
            <title>No ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
        </group_list>
        <measure>
          <title>(PAI-1) Plasminogen Activator Inhibitor -1 Antigen</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline, Pre- Cardiopulmonary bypass (CPD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.59" spread="2.36"/>
                    <measurement group_id="O2" value="3.78" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 30 minutes on CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.59" spread="2.8"/>
                    <measurement group_id="O2" value="17.8" spread="2.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Completion of CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.74" spread="6.63"/>
                    <measurement group_id="O2" value="58.56" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative day 1 (at 8:00AM)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.13" spread="12.14"/>
                    <measurement group_id="O2" value="88.74" spread="14.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>t-PA (Tissue-type Plasminogen Activator) Antigen</title>
        <time_frame>Baseline (prior to surgery) to postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACE Inhibitor</title>
            <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
          </group>
          <group group_id="O2">
            <title>No ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
        </group_list>
        <measure>
          <title>t-PA (Tissue-type Plasminogen Activator) Antigen</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline, Pre- Cardiopulmonary bypass (CPD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.81" spread="1.0"/>
                    <measurement group_id="O2" value="8.31" spread="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>On CPB for 30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.97" spread="5.43"/>
                    <measurement group_id="O2" value="20.44" spread="6.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At completion of CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.83" spread="1.84"/>
                    <measurement group_id="O2" value="28.03" spread="3.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative day 1 (at 8:00AM)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.36" spread="3.05"/>
                    <measurement group_id="O2" value="20.24" spread="1.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>ANOVA</method>
            <method_desc>Repeated measures</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IL-6 (Interleukin-6)</title>
        <time_frame>Baseline (pre-surgery) to postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACE Inhibitor</title>
            <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
          </group>
          <group group_id="O2">
            <title>No ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
        </group_list>
        <measure>
          <title>IL-6 (Interleukin-6)</title>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline, Pre- Cardiopulmonary bypass (CPD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.29" spread="1.27"/>
                    <measurement group_id="O2" value="3.06" spread="1.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>on CPB for 30min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.64" spread="3.23"/>
                    <measurement group_id="O2" value="13.08" spread="3.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At completion of CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="215.84" spread="32.59"/>
                    <measurement group_id="O2" value="141.00" spread="91.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative day 1 (at 8:00AM)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="401.69" spread="123.66"/>
                    <measurement group_id="O2" value="119.13" spread="33.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>ANOVA</method>
            <method_desc>Repeated measures</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IL-8 (Interleukin-8)</title>
        <time_frame>Baseline (pre-surgery) to postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACE Inhibitor</title>
            <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
          </group>
          <group group_id="O2">
            <title>No ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
        </group_list>
        <measure>
          <title>IL-8 (Interleukin-8)</title>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Before going on cardiopulmonary bypass</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.69" spread="2.07"/>
                    <measurement group_id="O2" value="15.56" spread="3.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 30 minutes on CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.76" spread="4.57"/>
                    <measurement group_id="O2" value="36.91" spread="16.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Admission to ICU following surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="213.74" spread="39.39"/>
                    <measurement group_id="O2" value="244.86" spread="121.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative day 1 (at 8:00AM)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="201.05" spread="66.91"/>
                    <measurement group_id="O2" value="127.03" spread="42.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.67</p_value>
            <method>ANOVA</method>
            <method_desc>Repeated measures</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>(MAP) Mean Arterial Blood Pressure</title>
        <time_frame>Baseline (prior to surgery) to postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACE Inhibitor</title>
            <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
          </group>
          <group group_id="O2">
            <title>No ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
        </group_list>
        <measure>
          <title>(MAP) Mean Arterial Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline, Pre- Cardiopulmonary bypass (CPD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.65" spread="1.68"/>
                    <measurement group_id="O2" value="47.82" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 30 minutes on CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.02" spread="3.16"/>
                    <measurement group_id="O2" value="53.52" spread="2.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At completion of CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.35" spread="4.23"/>
                    <measurement group_id="O2" value="59.48" spread="3.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative day 1 (at 8:00AM)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.63" spread="4.23"/>
                    <measurement group_id="O2" value="64.16" spread="3.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Bleeding</title>
        <description>Chest tube output at 4 and 24 hours after completion of surgery</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACE Inhibitor</title>
            <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
          </group>
          <group group_id="O2">
            <title>No ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Bleeding</title>
          <description>Chest tube output at 4 and 24 hours after completion of surgery</description>
          <units>mL/kg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Chest tube output in 4 hrs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.4" spread="13.8"/>
                    <measurement group_id="O2" value="19.8" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chest tube output in 24 hrs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.3" spread="20.7"/>
                    <measurement group_id="O2" value="43.2" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>P-value is for comparison of chest tube output at 24 hours</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.47</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Renal Function</title>
        <description>Acute kidney injury occurring</description>
        <time_frame>Baseline (prior to surgery) to postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACE Inhibitor</title>
            <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
          </group>
          <group group_id="O2">
            <title>No ACE Inhibitor</title>
            <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Renal Function</title>
          <description>Acute kidney injury occurring</description>
          <units>Percentage of subject with AKI</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.5"/>
                    <measurement group_id="O2" value="33.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.41</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From the start of surgery until hospital discharge, approximately 7 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ACE Inhibitor</title>
          <description>Patients already on an ACE inhibitor will continue it until the day of surgery
Angiotensin Converting Enzyme Inhibitor: Patients randomized to this group will continue their current dose of ACE inhibitors until surgery</description>
        </group>
        <group group_id="E2">
          <title>No ACE Inhibitor</title>
          <description>Patients on ACE inhibitors who are randomized to stop their ACE inhibitor 48 hours prior to surgery
No ACE Inhibitor: Patients randomized to this group will stop their ACE inhibitors 48 hours before surgery</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ECMO</sub_title>
                <description>Extracorporeal membrane oxygenation</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Surgical re-exploration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Permanent pacemaker</sub_title>
                <description>Did the patient require a permanent pacemaker after surgery?</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <description>Did the patient develop a pleural effusion?</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>While patients were randomized to preoperative ACE inhibition, the present study was neither blinded nor placebo-controlled. However, the dose and type of ACE inhibitor were similar between the two study groups.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Mias Pretorius</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>615-8757402</phone>
      <email>mias.pretorius@vanderbilt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

